Electric Literature of 4316-97-6, In the chemical reaction process,reaction time,type of solvent,can easily affect the result of the reaction, thereby determining the yield and properties of the reaction product.An updated downstream synthesis route of 4316-97-6 as follows.
Example 3; l-(4-(methylsulfonyl) phenyl)ethanone O-6-(4-(3-isopropyl-l,2,4-oxadiazol-5- yl)piperidin- 1 -yl)-5-methylpyrimidin-4-yl oxime; Step I: 5-(l-(6-chloro-5-methylpyrimidin-4-yl) piperidin-4-yl)-3-isopropyl- 1,2,4- oxadiazole.; A solution of 4-(3-isopropyl-l,2,4-oxadiazol-5-yl)piperidine hydrochloride (2.0 gm, 0.008369 moles) and diisopropylethylamine (2.78 gm, 0.0215 moles) in dichloromethane (30 ml) was added to an ice- cooled solution of 4,6-dichloro-5- methylpyrimidine (2.1 gm, 0.001295 moles) in dichloromethane (10 ml) and the reaction was stirred at 27 0C for 2 h. The reaction mixiure was diluted with dichloromethane and washed with water and brine, dried over sodium sulfate and evaporated under reduced pressure. The crude was purified by flash column chromatography (silica gel, 15% ethyl acetate in hexane) to afford the title compound as a white solid (43% yield).IHNMR (CDCl3, 400 MHZ) : 1.34 (6H, d, J=7.2 Hz), 1.99-2.08 (2H, m), 2.20 ( 2H, dd, J=13.2 &; 2.8 Hz), 2.25 (3H, s), 3.05-3.22 (4H, m), 4.34-4.37 (2H, m), 8.40 (IH, s).
These compound has a wide range of applications. It is believed that with the continuous development of the source of the synthetic route,4316-97-6, its application will become more common.
Reference:
Patent; CADILA HEALTHCARE LIMITED; PINGALI, Harikishore; JAIN, Mukul, R.; ZAWARE, Pandurang; WO2010/84512; (2010); A1;,
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia